Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial basliginda one cikan gelisme: Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.